XtalPi
PublicXtalPi is now publicly traded
The data on this page reflects XtalPi's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jun 13, 2024
Last Round
Follow-on Offering
Feb 19, 2025
Total Funding Raised
$1.18B
Company Overview
XtalPi is a research platform company that utilizes artificial intelligence (AI), quantum physics, and robotics to accelerate research and development in the life sciences and new materials industries. The company's Intelligent Digital Drug Discovery and Development (ID4) platform provides predictive models to improve the efficiency and success rate of drug discovery. It offers services and products to pharmaceutical, biotechnology, and chemical companies worldwide, with operations in both China and the United States. Founded in 2015 by physicists from MIT, the company went public on the Hong Kong Stock Exchange in June 2024.
Sector
Healthcare
AI Layer
Application
Keywords
XtalPi Comparables
Compare XtalPi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insilico Medicine | 88% | |
| Schrödinger | 83% | |
| Recursion Pharmaceuticals | 83% | |
XtalPi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Feb 19, 2025 | ||||
| IPO | Jun 13, 2024 | ||||
| Series D | Aug 11, 2021 | ||||
| Series C | Sep 28, 2020 | ||||
| Series B Extension | Oct 24, 2018 | ||||
Series B | Jan 23, 2018 |
XtalPi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SoftBank Investment Advisers | Series C |
| Yael Capital | Series B Extension |
| Mirae Asset | Series C |
| People's Insurance Company of China | Series C |
| CITIC Capital | Series C |
| 招银国际金融有限公司 | Series C |
| CITIC Securities | IPO |
XtalPi Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
